Articles
STUDIES CONCERNING THE OBTAINING OF A HIGH-CLASS DIGITALIS LANATA DRUG x
In future, an increase of these diseases and thus an increased demand for cardio-active drugs should be taken into account.
In cardiotherapy, the use of digitalis glycosides, mainly the glycosides C /digoxin and lanatoside C/ of Digitalis lanata, is preferred.
Prerequisite for the low-cost production of glycosides of the series C is the obtaining of a drug with a high and constant content of lanatoside C and content of digoxin, respectively.
The high content of lanatoside C has to correlate with a high yield of green mass /about 30 tons/hectare/ and the resistance to fungus attacks.
The Digitalis lanata of different origin which was at our disposal at the beginning of our studies, did not meet these demands /table 1/.
Table 1 – Content of lanatoside C of Digitalis lanata of different origin
| Origin | Content of lanatoside C / per cent/ |
| DSG | 0.12 |
| Poznan | 0.13 |
| Coimbra | 0.16 |
| Sofia | 0.14 |
| Warsaw | 0.13 |
| Krakow | 0.13 |
| Leipzig | 0.09 |
| Moscow | 0.13 |
By means of an individual selection in connection with the test of the descendants /see the following scheme/ it
